Weekly #7: Most Interesting D-Sheets from the Past Week
Week of May 25 – May 31, 2026 | $OML.V, $FSI, $NSYS, $OGD.TO & $ROMJ.V
Here are the InfoArb Tear Sheets we think you should pay the most attention to, where the differences between press releases and earnings calls are dramatic because they outline new catalysts, trends, and clarify misconceptions from just reading the press release.
These summaries are created to help you speed up your research on interesting companies. They are not buy/sell recommendations.
💡 These are tear sheet summaries; click any title to read the full tear sheet.
[OML.V] — Omni-Lite Industries Canada Inc. 🟢 Strong Signal
Description: Precision-components maker of mission-critical fasteners and parts for aerospace, defense, and electronics platforms. ~$16M cap, US$4.4M Q1 revenue.
Set-up: Beyond the 33% revenue beat, adjusted EBITDA rose 110% to ~US$858K with margin expanding to 19.6% from 12.3%, driven by mix and defense reorders rather than one-offs. It posted positive FCF with US$3.0M cash and no borrowings. The proof point is whether the H2 DP Cast pricing reset and reorders sustain the margin step-up.
Information arbitrage:
Three straight positive book-to-bill: Q1 booked US$4.9M at 1.12 book-to-bill into a record US$9.1M backlog — backlog becoming real revenue visibility.
Second-half pricing catalyst: Renegotiated DP Cast pricing carries flat-to-higher volumes with benefits back-end-loaded into H2.
Defense-program demand specifics: Demand tied to NATO munitions, missile defense, and air superiority, plus Inconel-fastener and supplier-replacement wins.
Risks: Q1 may have benefited from a favorable mix, management wouldn’t promise repeating, and DP Cast stays a drag until the H2 benefit lands; revenue is small and lumpy.
[FSI] — Flexible Solutions International, Inc. 🟡 Moderate Signal
Description: Specialty chemical and contract manufacturer shifting its NanoChem division toward food-grade/nutraceutical production while relocating legacy industrial and ag output to Panama. ~$81.6M cap, $8.3M Q1 revenue.
Set-up: Q1 looked like a modest improvement — revenue +11% and a slightly narrower net loss — but management framed it as the last quarter of a setup phase before a ramp. The call quantified the prize: the August 2025 food-grade contract is at full 24/7 production with a $6.5M annual minimum and >$25M potential, and combined contract potential exceeds $50M per year against a low single-digit-million base, with January-contract revenue expected in Q2 and profits rising into the second half. A reduced debt load, $2M+ of freed annual cash flow, and no planned equity actions support the ramp without near-term dilution.
Information arbitrage:
Capital-light upside: The August contract can reach $13–15M of sales with little capex and $25M with only $2–3M more, implying strong incremental returns if demand ramps.
Margin truth-telling: Food-division margins were accepted below preference (22–25% pre-tax target) to win volume and secure tariff/inflation protection, so not all new revenue is high-margin — a nuance the release buried.
Labor shifting from cost to revenue: Q4 training costs covered employees not yet producing; August-contract staff now generate revenue, and January-contract productivity improves weekly, explaining the sequential profit setup.
Risks: U.S. agriculture remains under extreme pressure, and the Florida LLC’s outstanding payments are uncertain, so the thesis depends on food-grade execution becoming large enough to overcome legacy-line weakness — and the profit inflection is still ahead of the reported numbers.
[NSYS] — Nortech Systems Incorporated 🟡 Moderate Signal
Description: Small-cap manufacturer of cable/PCB assemblies and system-level products for medical, industrial, and aerospace & defense. ~$38M cap, $30.3M Q1 revenue.
Set-up: Headline profit is thin ($47K operating income, small net loss), but the inflection is real: gross margin jumped 410 bps to 15.5% and adjusted EBITDA turned positive ($350K vs −$1.0M), a fourth straight positive quarter. A&D grew 41.2% and backlog rose to $90.8M. The question is whether thin margins keep expanding and convert to cash.
Information arbitrage:
A&D mix shift accelerating: Aerospace & defense up 41.2% YoY, far above company growth, after Bemidji transfers and approvals, with customer interest building in modern-warfare components like ruggedized fiber optics and tethered drones.
Backlog up despite shorter lead times: Backlog +17.4% from year-end, even as lead times fell from 100+ days to ~20, implying stronger underlying demand.
Tariff structure misread: Its Maquiladora setup leaves it not the U.S. importer of record on Mexico-made goods, cutting assumed tariff exposure.
Risks: Profitability is razor-thin (net loss of $34K, $1.6M operating cash use) with limited liquidity, and no analyst Q&A left the claims untested.
[OGD] — Orbit Garant Drilling Inc. 🟡 Moderate Signal
Description: Canadian mineral-drilling contractor serving mining and exploration customers, with revenue tied to rig utilization and pricing. ~$52M cap, CAD$51.4M Q3 revenue.
Set-up: Split screen — utilization hit a 10-year high of 67% (from 56% in Q1), but gross margin collapsed to 5.7% from 11.9% on weather, ramp-up costs, and legacy pricing. The rebound case: pricing pressure has “disappeared,” legacy contracts roll off April–June, and a new CAD$100M+ five-year contract is ramping (2 rigs deployed, 6 more by September). It only works if utilization finally converts to EBITDA.
Information arbitrage:
Dated legacy roll-off: Weak-priced contracts complete specifically in April, May, and June, giving a concrete window for margin drag to fade.
Revenue lag from ramp timing: Rigs mobilized in poor weather needed ramp-up, so Q3 understated utilization gains; Q4/Q1 should look better.
Inflation-protected new contracts: Many long-term deals now carry annual price-index (≥2%/CPI) plus labor/fuel clauses, limiting future margin-trap risk.
Risks: Q3 profitability cratered (adjusted EBITDA CAD$1.4M vs $5.4M) and recovery is unproven; the new contract needs CAD$20M capex with debt rising, and South America remains a drag.
[ROMJ.V] — Rubicon Organics Inc. 🟡 Moderate Signal
Description: Canadian premium/organic cannabis producer (1964, Simply Bare, Wildflower). ~$26M cap, CAD$13.7M Q1 revenue.
Set-up: A transitional quarter dressed as a setback — revenue grew 11%, but gross margin fell to 20% from 31%, and adjusted EBITDA swung to −$0.6M as the new Cascadia indoor facility carried pre-revenue costs. The H2 thesis is Cascadia commercializing (~40% added capacity) to absorb fixed costs, plus automation and international growth. Management pegs the ex-Cascadia margin at ~29%, and Rubicon is gaining share in a shrinking premium market.
Information arbitrage:
Margin masked by Cascadia drag: Gross margin would have been ~29% (vs 20% reported), excluding Cascadia’s temporary pre-revenue costs.
Share gains in a shrinking category: Canada’s premium market fell ~8% (≈CAD$197M to $181M), yet Rubicon grew share and dollars sold.
International already real: International revenue was just under CAD$1M in Q1, with management targeting ~10% of 2026 sales.
Risks: Adjusted EBITDA is negative, and cash is only CAD$3.2M against a CAD$5.2M capex plan; the indoor ramp can take 18–24 months to dial in (one favored strain already failed to transfer).